Xpert® Bladder Cancer Detection

Home / Tests / Oncology & Human Genetics

Detection of the presence of bladder cancer in patients with hematuria in around 90 minutes

Test pack size(s)

10 Tests

GXBLAD-CD-CE-10

Qty

Unit price

Subtotal

USD

Collection devices

Kit, Xpert Urine Transport Reagent Kit (30 Collection Devices)

GXUTR-CE-30

Qty

Unit price

Subtotal

USD

Total

Error adding items to cart. If this error persists, please contact Digital Support

List name

Label

Having trouble? Contact Cepheid Digital Support

The Need

Early and accurate diagnosis of bladder cancer is critical in patients with hematuria.³

Four out of five people with bladder cancer have blood in their urine⁴
But 80–90% of patients with visible hematuria, and over 95% of patients with non-visible hematuria do NOT have cancer
There are many known causes of hematuria including urinary tract infection, nephrolitiasis (stones), etc⁴
In patients with hematuria, it can be difficult to decide which patients might have cancer and which patients might have a different condition
Primary care physicians are sometimes reluctant to refer patients with visible or significant microscopic hematuria to urology for further investigation⁵

3 Kamat AM, et al. Bladder Cancer. Lancet. 2016 Dec 3;388(10061):2796-2810.
4 Avellino G, et al. Diagnosis and Management of hematuria. Surg Clin North Am. 2016 Jun;96(3): 503-15.
5 Yafi FA, et al. Patients with microscopic and gross hematuria: practice and referral patterns among primary care physicians in a universal health care system. Can Urol Assoc J 2011;5(2):97-101.

The Solution

Xpert Bladder Cancer Detection is a non-invasive biomarker test for patients with hematuria that is used in conjunction with other clinical measures.

Five mRNA biomarkers were intensively validated for the detection of bladder cancer
The non-invasive and painless test uses voided urine samples
The test is performed using a self-contained cartridge and system, and can be performed in any size urology lab
Each cartridge contains three controls for dependable results
Sample stability for up to 7 days in Xpert® Urine Transport Reagent
The test enables flexible testing as require

The Impact

A test that helps clinicians gain additional information for patients with hematuria.

Non-invasive test to reduce patients’ anxiety, pain, and embarrassment⁶
High negative predictive value may help patients avoid unnecessary procedures and discomfort⁷
Easy to implement and train
Robust test and workflow with decentralized laboratory testing

6 Biardeau X, et al. Prospective evaluation of anxiety, pain, and embarrassment associated with cystoscopy and urodynamic testing in clinical practice. Can Urol Assoc J. 2017 Mar-Apr; 11(3-4): 104–110.
7 Todenhöfer, et al. Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer. BMC Cancer. 2015 Mar 19;15:155.